Physicians often use esophageal cancer survival rates to estimate a patient’s prognosis, although they also take a number of individual factors into account that can also influence a patient’s chance of survival.
- The types of treatment a patient receives – Generally speaking, patients whose cancers can be resected, or surgically removed, have higher survival rates. Multimodal treatments (surgery combined with chemotherapy, radiation therapy or both) have also been associated with an increase in survival.
- The histological type (cell type) of the cancer – There are two main types of esophageal cancer: adenocarcinoma and squamous cell carcinoma. Patients with squamous cell carcinoma tend to have better outcomes than patients with adenocarcinoma.
- The treatments available at the time a patient is diagnosed – The current five-year survival rate is based on patients who were diagnosed more than eight years ago. However, treatments have become much more advanced in the past few years. Although updated statistics aren’t yet available, researchers generally expect an increase in survival rates as newer, more effective treatments are discovered.
At Moffitt Cancer Center, we’re at the forefront of treatment research with one of the most robust clinical trial programs in the state of Florida. What’s more, we don’t believe the general survival rate is a true predictor of what’s possible with exceptional care. We create individualized, multispecialty treatment plans for all of our patients, working to improve not only their prognosis but also their quality of life.
If you’d like more information about the esophageal cancer survival rate or Moffitt’s approach to treating esophageal cancer, call 1-888-663-3488 or request an appointment online – no referral is required.